0001373604-24-000035.txt : 20240613 0001373604-24-000035.hdr.sgml : 20240613 20240613180427 ACCESSION NUMBER: 0001373604-24-000035 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240611 FILED AS OF DATE: 20240613 DATE AS OF CHANGE: 20240613 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Leonard Braden Michael CENTRAL INDEX KEY: 0001373603 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37581 FILM NUMBER: 241042432 MAIL ADDRESS: STREET 1: 156 S. FIRST STREET CITY: ZIONSVILLE STATE: IN ZIP: 46077 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aclaris Therapeutics, Inc. CENTRAL INDEX KEY: 0001557746 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 460571712 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 701 LEE ROAD STREET 2: SUITE 103 CITY: WAYNE STATE: PA ZIP: 19087 BUSINESS PHONE: 484-324-7933 MAIL ADDRESS: STREET 1: 701 LEE ROAD STREET 2: SUITE 103 CITY: WAYNE STATE: PA ZIP: 19087 4 1 form4.xml X0508 4 2024-06-11 0001557746 Aclaris Therapeutics, Inc. ACRS 0001373603 Leonard Braden Michael 65 E CEDAR - SUITE 2 ZIONSVILLE IN 46077 true false Common Stock 2024-06-11 4 P 0 1000000 1.08 A 10395934 I Holding of BML Investment Partners, L.P. Common Stock 2024-06-12 4 P 0 82579 1.14 A 10478513 I Holding of BML Investment Partners, L.P. Common Stock 2024-06-13 4 P 0 28621 1.1445 A 10507134 I Holding of BML Investment Partners, L.P. Common Stock 2024-06-13 4 P 0 500000 1.15 A 11007134 I Holding of BML Investment Partners, L.P. BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. Represents shares purchased in multiple transactions resulting in a weighted average purchase price of $1.14 per share. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range. Represents shares purchased in multiple transactions resulting in a weighted average purchase price of $1.1445 per share. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range. Braden Michael Leonard 2024-06-13